Contact us for product
availability and pricing.

Explore InLighta’s Valuable Resources

Empowering Discovery,
Enhancing Knowledge

Latest News

Stay updated with the latest news and developments from InLighta BioSciences.
October 20, 2020

InLighta BioSciences Awarded NIH Grant

InLighta BioSciences, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded an NIH grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis.

February 10, 2020

Health Imaging Reports on InLighta’s Liver Cancer Biomarker Targeting

Health Imaging recently reported InLighta’s development of a protein-based MRI contrast agent designed to target liver cancer biomarkers for earlier cancer detection.

February 7, 2020

Study on Early-Stage Liver Cancer Detection

A study reporting a new method to detect early-stage liver cancer was recently published in the journal Science Advances. This method uses a protein-based MRI contrast agent targeting the CXCR4 receptor associated with certain metastatic cancer cells, and a new precision MRI (pMRI) imaging methodology, to enable earlier detection of cancer. Early detection is expected to result in better treatment options and improved patient outcomes.

This new technology was developed in the lab of Dr. Jenny Yang at Georgia State University, and collaborator’s from Emory University, and was recently featured in a GSU media release.

January 24, 2020

Collagen-targeted MRI contrast agent for liver fibrosis detection.

Nature Reviews Gastroenterology and Hepatology recently published a review about InLighta’s collagen-targeted MRI contrast agent for liver fibrosis, which provides direct quantification of collagen deposition in preclinincal liver disease models.

InLighta Patents

InLightaTM BioSciences L.L.C. currently has exclusive operational agreement with Georgia State University for a robust patent portfolio (18 issued and pending patents) related to targeted and non-targeted protein-based contrast agents in the U.S. and various international markets including China, Japan, Canada, Germany, France and the U.K.

Academic Papers and Presentations by Dr. Jenny Yang

Explore Dr. Jenny Yang’s related academic papers, conference presentations, and more.

Load More